Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Activated leukocyte cell adhesion molecule: a new paradox in cancer.

Ofori-Acquah SF, King JA.

Transl Res. 2008 Mar;151(3):122-8. doi: 10.1016/j.trsl.2007.09.006. Epub 2007 Oct 23. Review.

PMID:
18279810
2.

MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma.

Verma A, Shukla NK, Deo SV, Gupta SD, Ralhan R.

Oncology. 2005;68(4-6):462-70. Epub 2005 Jul 13.

PMID:
16024937
3.

MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).

Degen WG, van Kempen LC, Gijzen EG, van Groningen JJ, van Kooyk Y, Bloemers HP, Swart GW.

Am J Pathol. 1998 Mar;152(3):805-13.

4.

ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.

Jezierska A, Matysiak W, Motyl T.

Med Sci Monit. 2006 Aug;12(8):BR263-73. Epub 2006 Jul 12.

PMID:
16865058
5.

Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.

van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW.

Am J Pathol. 2000 Mar;156(3):769-74.

6.

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.

King JA, Ofori-Acquah SF, Stevens T, Al-Mehdi AB, Fodstad O, Jiang WG.

Breast Cancer Res. 2004;6(5):R478-87. Epub 2004 Jun 28.

7.

Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.

Miccichè F, Da Riva L, Fabbi M, Pilotti S, Mondellini P, Ferrini S, Canevari S, Pierotti MA, Bongarzone I.

PLoS One. 2011 Feb 22;6(2):e17141. doi: 10.1371/journal.pone.0017141.

8.

ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.

Jannie KM, Stipp CS, Weiner JA.

PLoS One. 2012;7(6):e39330. doi: 10.1371/journal.pone.0039330. Epub 2012 Jun 26.

9.

Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?

Swart GW, Lunter PC, Kilsdonk JW, Kempen LC.

Cancer Metastasis Rev. 2005 Jun;24(2):223-36. Review.

PMID:
15986133
11.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.

Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, Izbicki JR, Bockhorn M.

J Surg Res. 2012 Sep;177(1):e15-20. doi: 10.1016/j.jss.2012.02.013. Epub 2012 Mar 30.

PMID:
22482754
12.

Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.

van Kempen LC, Meier F, Egeblad M, Kersten-Niessen MJ, Garbe C, Weidle UH, Van Muijen GN, Herlyn M, Bloemers HP, Swart GW.

J Invest Dermatol. 2004 May;122(5):1293-301.

13.

Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.

King JA, Tan F, Mbeunkui F, Chambers Z, Cantrell S, Chen H, Alvarez D, Shevde LA, Ofori-Acquah SF.

Mol Cancer. 2010 Oct 7;9:266. doi: 10.1186/1476-4598-9-266.

14.

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.

Ihnen M, Müller V, Wirtz RM, Schröder C, Krenkel S, Witzel I, Lisboa BW, Jänicke F, Milde-Langosch K.

Breast Cancer Res Treat. 2008 Dec;112(3):419-27. doi: 10.1007/s10549-007-9879-y. Epub 2008 Jan 3.

PMID:
18172759
15.

Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.

van Kilsdonk JW, Wilting RH, Bergers M, van Muijen GN, Schalkwijk J, van Kempen LC, Swart GW.

Cancer Res. 2008 May 15;68(10):3671-9. doi: 10.1158/0008-5472.CAN-07-5767.

16.

Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.

van Kilsdonk JW, Takahashi N, Weidle U, Burtscher H, Jarry J, Daha MR, Swart GW, van Kempen LC.

J Invest Dermatol. 2012 May;132(5):1462-70. doi: 10.1038/jid.2011.487. Epub 2012 Feb 9.

17.

Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.

van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, Bloemers HP, Figdor CG, Swart GW.

J Biol Chem. 2001 Jul 13;276(28):25783-90. Epub 2001 Apr 16.

18.

Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration.

Masedunskas A, King JA, Tan F, Cochran R, Stevens T, Sviridov D, Ofori-Acquah SF.

FEBS Lett. 2006 May 15;580(11):2637-45. Epub 2006 Apr 21.

19.

Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.

Piao D, Jiang T, Liu G, Wang B, Xu J, Zhu A.

Mol Biol Rep. 2012 Jan;39(1):661-8. doi: 10.1007/s11033-011-0783-5. Epub 2011 Jun 14.

PMID:
21670959
20.

Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

Ihnen M, Köhler N, Kersten JF, Milde-Langosch K, Beck K, Höller S, Müller V, Witzel I, Jänicke F, Kilic E.

Dis Markers. 2010;28(2):71-8. doi: 10.3233/DMA-2010-0685.

Items per page

Supplemental Content

Write to the Help Desk